cyano-3-(5-phenoxypentyl)(pyridin-4-yl)guanidine

ID: ALA322225

PubChem CID: 18365476

Max Phase: Preclinical

Molecular Formula: C18H21N5O

Molecular Weight: 323.40

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N#CN(C(=N)NCCCCCOc1ccccc1)c1ccncc1

Standard InChI:  InChI=1S/C18H21N5O/c19-15-23(16-9-12-21-13-10-16)18(20)22-11-5-2-6-14-24-17-7-3-1-4-8-17/h1,3-4,7-10,12-13H,2,5-6,11,14H2,(H2,20,22)

Standard InChI Key:  FJZCMMCVSNUIEO-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 25  0  0  0  0  0  0  0  0999 V2000
    3.5542   -1.3125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3792   -1.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1417   -2.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7292   -2.7417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7917   -2.0292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1417   -0.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3167    0.8333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7917   -0.5917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3167   -0.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5542    0.1208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3292   -2.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5042   -2.7417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9042    0.1208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1417    0.8333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6167   -0.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0917   -2.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7417   -2.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7417   -3.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0292   -1.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2667   -2.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8542   -1.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5667   -3.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5667   -2.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9792   -2.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  3  3  0
  5  2  2  0
  6  1  1  0
  7 14  1  0
  8  2  1  0
  9  6  2  0
 10  6  1  0
 11 12  1  0
 12 16  1  0
 13  9  1  0
 14 10  2  0
 15  8  1  0
 16 20  1  0
 17 11  1  0
 18 11  2  0
 19 15  1  0
 20 21  1  0
 21 19  1  0
 22 18  1  0
 23 17  2  0
 24 22  2  0
  7 13  2  0
 24 23  1  0
M  END

Alternative Forms

Associated Targets(Human)

NSCLC (640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16 (5829 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lewis lung carcinoma cell line (1243 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
YOSHIDA (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
WALKER (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 323.40Molecular Weight (Monoisotopic): 323.1746AlogP: 3.14#Rotatable Bonds: 8
Polar Surface Area: 85.03Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.40CX LogP: 2.82CX LogD: 2.82
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.26Np Likeness Score: -0.61

References

1. Schou C, Ottosen ER, Petersen HJ, Bjorkling F, Latini S, Hjarnaa PV, Bramm E, Binderup L.  (1997)  Novel cyanoguanidines with potent oral antitumour activity,  (24): [10.1016/S0960-894X(97)10152-4]

Source